Atopic dermatitis is an allergic disease involving chronic and recurrent itching and dermatitis and is one of the most frequently treated chronic diseases in the field of traditional Korean medicine (TKM).[@bib0005] The personal health record (PHR) platform can accumulate information on daily symptoms of individual patients and will not only aid healthcare of patients with chronic disease, but also of those receiving TKM treatment, where long-term observation of symptoms is important.[@bib0010] The Korea Institute of Oriental Medicine has developed a PHR platform for the management of atopic dermatitis (AtopyPHR).[@bib0015] The AtopyPHR menu comprises a dashboard, check log, daily checks, and health records. Patients can record atopic symptoms through health records and a daily check menu, and monitor their own health status through the dashboard menu. The check log menu is used to determine what items were recorded daily by users. Dashboard screens can be shared with TKM doctors. Items displayed on the dashboard screen that is shared by the patient and the TKM doctor include the severity scoring of atopic dermatitis (SCORAD),[@bib0020] daily check, food management, daily emotions, stool-urine-sleep, and symptom photography (supplement 1). In this study, to investigate the usefulness of the AtopyPHR in a real environment, we surveyed patients with atopic dermatitis who used the AtopyPHR while receiving medical treatment at a TKM hospital.

The study included both patients diagnosed with atopic dermatitis and their parents. Prior to receiving TKM treatment, the participants were trained to use the AtopyPHR. After 6 weeks of using the AtopyPHR with TKM treatment, the usefulness of the AtopyPHR was evaluated via a questionnaire. The questionnaire comprised 21 items in three categories, including the participant's socio-demographic information, usefulness of the AtopyPHR, and matters needing improvement (supplement 2). The survey was conducted using a survey menu that was embedded within the AtopyPHR. Categorical data were summarized using frequency and percentages, and continuous data were summarized using the average ± standard deviation. The reliability of the survey items was assessed by Cronbach's α. An independent t-test was used to compare the survey results according to user group. P-values less than 0.05 were considered statistically significant, and SPSS 24.0 (IBM Co., Armonk, NY, USA) was used for analysis.

The study included 126 participants, of which 30 were patients and 96 were parents of patients. Details of respondent demographics are listed in Supplement 3. Cronbach's α for measuring internal consistency was 0.933. Participants reported in the questionnaire that the AtopyPHR was useful, with an average of 4.13, 4.12, 4.12 points on a scale of 1--5 points reflecting usefulness by function, usefulness by item, and overall usefulness, respectively ([Table 1](#tbl0005){ref-type="table"}). Compared to the patients' usefulness scores, parental scores tended to be higher; however, there was no statistical difference. To improve the functions of the AtopyPHR, users suggested we provide information on medical and healthcare methods according to atopic dermatitis symptoms and diversify data visualizations to provide users with a single view of their life patterns or health checks. There were also suggestions about ease of access to input information and ease of recording.Table 1Results of the usefulness assessment.Table 1VariablesTotalInformation providerP-valueParents (n = 96)Patients (n = 30)Overall usefulnessImproved health-care interests4.2 ± 0.84.3 ± 0.73.9 ± 0.80.137Help with health care4.2 ± 0.84.3 ± 0.74.0 ± 0.80.301Help with treatment4.1 ± 0.84.2 ± 0.74.0 ± 0.80.509Willingness to recommend the app4.0 ± 0.84.0 ± 0.83.8 ± 0.10.253Usefulness by functionDashboards4.1 ± 0.94.2 ± 0.83.9 ± 1.00.281Daily Checks4.2 ± 0.84.2 ± 0.74.0 ± 1.00.176Usefulness by itemSeverity scoring of atopic dermatitis (SCORAD)4.1 ± 0.84.1 ± 0.83.9 ± 0.90.566Atopic daily check4.1 ± 0.84.2 ± 0.73.9 ± 0.90.343Dietary score4.2 ± 0.84.3 ± 0.84.0 ± 1.00.453Daily emotion3.9 ± 0.93.9 ± 1.04.0 ± 0.80.377Stool-urine-sleep4.1 ± 0.94.1 ± 0.93.9 ± 0.80.139Symptom photography4.0 ± 1.04.1 ± 0.93.8 ± 1.10.223[^2][^3]

We conducted this study by teaching patients with atopic dermatitis who were willing to receive TKM treatment how to use the AtopyPHR, and our results show that AtopyPHR may be useful for disease management in these patients. Users' opinions from the survey will help us improve the usefulness of the AtopyPHR.
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